Measurement of Hemoglobin A1c from Filter Papers for Population-Based Studies
- 1 April 2011
- journal article
- research article
- Published by Oxford University Press (OUP) in Clinical Chemistry
- Vol. 57 (4) , 577-585
Abstract
BACKGROUND: Stability and transport challenges make hemoglobin (Hb) A1c measurement from EDTA whole blood (WB) inconvenient and costly for large-scale population studies. This study investigated Hb A1c measurement from WB blotted on filter paper (FP) in a Level I National Glycohemoglobin Standardization Program (NGSP)-accredited laboratory. METHODS: Three Bio-Rad Variant™ II HPLC instruments and WB and FP specimens were used. Precision, accuracy, linearity, and readable total area of the 6.5-min (β-thalassemia method) Variant II HbA2/HbA1c Dual Program were assessed. Hb A1c stability was measured using in-house FP QC samples. The INTERHEART (a study of the effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries) and CURE (Clopidogrel in Unstable Angina to Prevent Recurrent Events) studies provided chromatographs for morphometric analyses and interoperator variability experiments. Statistical analyses were performed to assess long-term sample stability, WB vs FP agreement, and significance of Hb A1c peak integration. RESULTS: Intra- and interassay CVs were ≤2.00%. Total area counts between 0.8 and 5.5 × 106 μV/s produced accurate Hb A1c results. The regression equation for agreement between WB(x) and FP(y) was as follows: y = 0.933x + 0.4 (n = 85). FP QC samples stored at −70 °C and tested over approximately 3 years yielded CVs of 1.72%–2.73% and regression equations with slopes of −1.08 × 10−4 to 7.81 × 10−4. The CURE study, with better preanalytical preparation, achieved a 97% reportable rate, and the reportable rate of the INTERHEART study was 85%. CONCLUSIONS: The FP collection method described provided accurate, robust, and reproducible measurement of Hb A1c using the Bio-Rad Variant II HPLC autoanalyzer when FP specimens were prepared according to standardized protocols, and analyses were performed in an NGSP-certified laboratory, supporting the use of FP collection cards in large multinational studies.Keywords
This publication has 30 references indexed in Scilit:
- The Effect of Intensive Glycemic Treatment on Coronary Artery Calcification in Type 1 Diabetic Participants of the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) StudyDiabetes, 2006
- Stability of haemoglobin A1c (HbA1c) measurements from frozen whole blood samples stored for over a decadeDiabetic Medicine, 2005
- HPLC Retention Time as a Diagnostic Tool for Hemoglobin Variants and Hemoglobinopathies: A Study of 60000 Samples in a Clinical Diagnostic LaboratoryClinical Chemistry, 2004
- Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control studyThe Lancet, 2004
- Silent haemoglobin variants and determination of HbA1c with the HPLC Bio-Rad Variant IIJournal of Clinical Pathology, 2002
- Retinopathy and Nephropathy in Patients with Type 1 Diabetes Four Years after a Trial of Intensive TherapyNew England Journal of Medicine, 2000
- Capillary Blood on Filter Paper for Determination of HbA1c by Ion Exchange ChromatographyDiabetes Care, 1996
- The Effect of Intensive Treatment of Diabetes on the Development and Progression of Long-Term Complications in Insulin-Dependent Diabetes MellitusNew England Journal of Medicine, 1993
- The Clinical Information Value of the Glycosylated Hemoglobin AssayNew England Journal of Medicine, 1984
- Red cell age-related changes of hemoglobins AIa+b and AIc in normal and diabetic subjects.Journal of Clinical Investigation, 1976